Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-29 @ 3:23 AM
Study NCT ID:
NCT03393520
Status:
COMPLETED
Last Update Posted:
2024-11-20
First Post:
2018-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-03
First Submit QC Date:
None
Study First Post Date:
2018-01-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-04-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-11-15
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL